Literature DB >> 316267

Immunobiology of paediatric intracranial tumours. A preliminary report.

M Gerosa, G Amadori, C Semenzato, R Raumer, P Cisotto, A Pezzuto, G Gasparotto, A Carteri.   

Abstract

Preliminary findings in the evaluation of the immune response of children with primary neoplasms of the CNS, mainly medulloblastomas, are reported and discussed. A broad scheme for the monitoring of B- and T-cell-dependent immunity and of delayed hypersensitivity reactions in this type of patient is presented. The most important immunobiological findings are discussed. Special attention is given to the striking failure of the T-cell-dependent pool (currently identified by "active" RFC and blastigenesis tests) and to the remarkable decrease of hypersensitivity reactions (depressed skin-test response), both of which seem to be related to the degree of malignancy of the tumour. A very peculiar feature, i.e., the appearance of cells with natural cytotoxic activity, is dealt with in some detail. Our present knowledge concerning the immunobiology of primary CNS neoplasms is still very incomplete, but seems to suggest a possible role for immunotherapy in paediatric neurosurgery.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316267     DOI: 10.1007/bf01813548

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  10 in total

1.  Improvement of phytohemagglutinin responsiveness of lymphocytes from cancer patients after washing in vitro.

Authors:  J A Mannick; M Constantian; D Pardrige; I Saporoschetz; A Badger
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

2.  In vitro demonstration of cell-mediated immunity to human brain tumors.

Authors:  N L Levy; M S Mahaley; E D Day
Journal:  Cancer Res       Date:  1972-03       Impact factor: 12.701

3.  Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma.

Authors:  J Stjernswärd; M Jondal; F Vánky; H Wigzell; R Sealy
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Contactual lysis of antibody-coated chicken erythrocytes by purified lymphocytes.

Authors:  P Perlmann; H Perlmann
Journal:  Cell Immunol       Date:  1970-09       Impact factor: 4.868

6.  Spontaneous lymphocyte transformation in chronic lymphocytic leukaemia.

Authors:  G Semenzato; G Amadori; F Tosato; G Gasparotto
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

7.  T-cell deficiency in patients with squamous cell cancer of the head and neck.

Authors:  H J Wanebo; M Y Jun; E W Strong; H Oettgen
Journal:  Am J Surg       Date:  1975-10       Impact factor: 2.565

8.  Spontaneous, augmentable cell-mediated cytotoxicity with limited target cell specificity in human blood.

Authors:  E Saksela; T Imir; O Mäkelä
Journal:  Eur J Immunol       Date:  1977-03       Impact factor: 5.532

9.  A modified assay for the detection of human adult active rosette forming lymphocytes.

Authors:  R Smith; R Kerman; E Ezdinli; S Stefani
Journal:  J Immunol Methods       Date:  1975       Impact factor: 2.303

10.  Immunological monitoring and immunotherapy in carcinoma of the lung.

Authors:  J L Weese; R B Herberman; E Perlin; M Mills; W Heims; J Blom; D Green; J Reid; S Bellinger; I Law; J L McCoy; J H Dean; G B Cannon; J Djeu
Journal:  Int J Cancer       Date:  1976-12-15       Impact factor: 7.396

  10 in total
  4 in total

Review 1.  Medulloblasoma: challenges for effective immunotherapy.

Authors:  Adam M Sonabend; Alfred T Ogden; Lisa M Maier; David E Anderson; Peter Canoll; Jeffrey N Bruce; Richard C E Anderson
Journal:  J Neurooncol       Date:  2011-12-16       Impact factor: 4.130

2.  Immunological monitoring of patients affected by anaplastic glioma concerning in effects of surgery, radio-, and chemotherapy. A preliminary report.

Authors:  F Servadei; R Parente; F Spagnolli; G Gaist; R Padovani; M Bucci; L Steiner
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

3.  The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.

Authors:  M L Apuzzo; K M Sheikh; M H Weiss; J S Heiden; T Kurze
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

Review 4.  Immunotherapy for Medulloblastoma: Current Perspectives.

Authors:  Tanvir F Kabir; Charles A Kunos; John L Villano; Aman Chauhan
Journal:  Immunotargets Ther       Date:  2020-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.